Targeting molecular networks for drug research

The study of molecular networks has recently moved into the limelight of biomedical research. While it has certainly provided us with plenty of new insights into cellular mechanisms, the challenge now is how to modify or even restructure these networks. This is especially true for human diseases, which can be regarded as manifestations of distorted states of molecular networks. Of the possible interventions for altering networks, the use of drugs is presently the most feasible. In this mini-review, we present and discuss some exemplary approaches of how analysis of molecular interaction networks can contribute to pharmacology (e.g., by identifying new drug targets or prediction of drug side effects), as well as list pointers to relevant resources and software to guide future research. We also outline recent progress in the use of drugs for in vitro reprogramming of cells, which constitutes an example par excellence for altering molecular interaction networks with drugs.

[1]  Diogo M. Camacho,et al.  Wisdom of crowds for robust gene network inference , 2012, Nature Methods.

[2]  Michael J. Keiser,et al.  Predicting new molecular targets for known drugs , 2009, Nature.

[3]  Erich E. Wanker,et al.  UniHI: an entry gate to the human protein interactome , 2006, Nucleic Acids Res..

[4]  Hongkang Mei,et al.  Systematic Prediction of Pharmacodynamic Drug-Drug Interactions through Protein-Protein-Interaction Network , 2013, PLoS Comput. Biol..

[5]  D. di Bernardo,et al.  Reverse engineering a mouse embryonic stem cell-specific transcriptional network reveals a new modulator of neuronal differentiation , 2012, Nucleic acids research.

[6]  A. Hopkins Network pharmacology: the next paradigm in drug discovery. , 2008, Nature chemical biology.

[7]  Khusru Asadullah,et al.  What makes a good drug target? , 2011, Drug discovery today.

[8]  P. Bork,et al.  Drug Target Identification Using Side-Effect Similarity , 2008, Science.

[9]  E. Tobinick The value of drug repositioning in the current pharmaceutical market. , 2009, Drug news & perspectives.

[10]  Erich E. Wanker,et al.  Comparison of Human Protein-Protein Interaction Maps , 2007, German Conference on Bioinformatics.

[11]  S. Mathur,et al.  Drug repositioning using disease associated biological processes and network analysis of drug targets. , 2011, AMIA ... Annual Symposium proceedings. AMIA Symposium.

[12]  B. Al-Lazikani,et al.  Combinatorial drug therapy for cancer in the post-genomic era , 2012, Nature Biotechnology.

[13]  A. Wagner Distributed robustness versus redundancy as causes of mutational robustness. , 2005, BioEssays : news and reviews in molecular, cellular and developmental biology.

[14]  Christopher L. McClendon,et al.  Reaching for high-hanging fruit in drug discovery at protein–protein interfaces , 2007, Nature.

[15]  N. Katsanis,et al.  Human genetics and disease: Beyond Mendel: an evolving view of human genetic disease transmission , 2002, Nature Reviews Genetics.

[16]  Yoshihiro Yamanishi,et al.  Prediction of drug–target interaction networks from the integration of chemical and genomic spaces , 2008, ISMB.

[17]  Sunghoon Kim,et al.  Rational drug repositioning guided by an integrated pharmacological network of protein, disease and drug , 2012, BMC Systems Biology.

[18]  S. Yamanaka,et al.  Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors , 2006, Cell.

[19]  Illés J. Farkas,et al.  Uniformly curated signaling pathways reveal tissue-specific cross-talks and support drug target discovery , 2010, Bioinform..

[20]  Yoshihiro Yamanishi,et al.  Relating drug–protein interaction network with drug side effects , 2012, Bioinform..

[21]  R. Tagliaferri,et al.  Discovery of drug mode of action and drug repositioning from transcriptional responses , 2010, Proceedings of the National Academy of Sciences.

[22]  F. Prinz,et al.  Believe it or not: how much can we rely on published data on potential drug targets? , 2011, Nature Reviews Drug Discovery.

[23]  Ruth Nussinov,et al.  Structure and dynamics of molecular networks: A novel paradigm of drug discovery. A comprehensive review , 2012, Pharmacology & therapeutics.

[24]  H. Deng,et al.  Pluripotent Stem Cells Induced from Mouse Somatic Cells by Small-Molecule Compounds , 2013, Science.

[25]  Matthias E. Futschik,et al.  UniHI 7: an enhanced database for retrieval and interactive analysis of human molecular interaction networks , 2013, Nucleic Acids Res..

[26]  Y. Moreau,et al.  Finding the targets of a drug by integration of gene expression data with a protein interaction network. , 2013, Molecular bioSystems.

[27]  Damian Szklarczyk,et al.  STITCH 3: zooming in on protein–chemical interactions , 2011, Nucleic Acids Res..

[28]  John P. Overington,et al.  How many drug targets are there? , 2006, Nature Reviews Drug Discovery.

[29]  Teri A Manolio,et al.  Genomewide association studies and assessment of the risk of disease. , 2010, The New England journal of medicine.

[30]  Julio Saez-Rodriguez,et al.  DvD: An R/Cytoscape pipeline for drug repurposing using public repositories of gene expression data , 2012, Bioinform..

[31]  Wenjun Guo,et al.  Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds , 2008, Nature Biotechnology.

[32]  David S. Wishart,et al.  DrugBank 3.0: a comprehensive resource for ‘Omics’ research on drugs , 2010, Nucleic Acids Res..

[33]  P. Bork,et al.  A side effect resource to capture phenotypic effects of drugs , 2010, Molecular systems biology.

[34]  Uma Lakshmipathy,et al.  Pluripotent Stem Cells , 2013, Methods in Molecular Biology.

[35]  Chuang Liu,et al.  Prediction of Drug-Target Interactions and Drug Repositioning via Network-Based Inference , 2012, PLoS Comput. Biol..

[36]  R. Albert Scale-free networks in cell biology , 2005, Journal of Cell Science.

[37]  M. Oti,et al.  The modular nature of genetic diseases , 2006, Clinical genetics.

[38]  A. Barabasi,et al.  Drug—target network , 2007, Nature Biotechnology.

[39]  J. Hopfield,et al.  From molecular to modular cell biology , 1999, Nature.

[40]  A. Barabasi,et al.  Network medicine : a network-based approach to human disease , 2010 .

[41]  José Pedro Basto Gouveia Pereira Pinto Computational tools for large-scale biological network analysis , 2012 .

[42]  W-C Hwang,et al.  Identification of Information Flow‐Modulating Drug Targets: A Novel Bridging Paradigm for Drug Discovery , 2008, Clinical pharmacology and therapeutics.

[43]  A. Bonato,et al.  Dominating Biological Networks , 2011, PloS one.

[44]  Lin He,et al.  DRAR-CPI: a server for identifying drug repositioning potential and adverse drug reactions via the chemical–protein interactome , 2011, Nucleic Acids Res..

[45]  Philip E. Bourne,et al.  PROMISCUOUS: a database for network-based drug-repositioning , 2010, Nucleic Acids Res..

[46]  Jennifer Nichols,et al.  Promotion of Reprogramming to Ground State Pluripotency by Signal Inhibition , 2008, PLoS biology.